mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.02 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.02 |
mRNA |
CGP-082996 |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
0.02 |
mRNA |
AT-406 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.02 |
mRNA |
NSC632839 |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.02 |
mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.02 |
mRNA |
ouabain |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.02 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.02 |
mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.02 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.02 |